Clinical Trials Browser

Phase 3 × Skin Neoplasms × linrodostat × Clear all

NCT03329846 2021-07-09

An Investigational Immuno-therapy Study of BMS-986205 Combined With Nivolumab, Compared to Nivolumab by Itself, in Patients With Advanced Melanoma

Phase 3 Completed

20 enrolled 10 charts

Melanoma, Skin Neoplasms